VB Spine, the largest privately held spine company, announced it has entered into a definitive agreement to acquire exclusive rights to the xvision Spine System® (xvision) from Augmedics, adding augmented reality (AR) navigation to VB Spine’s growing enhanced visualization portfolio. Augmedics is the first company to offer an FDA-cleared AR navigation platform in spine surgery, positioning VB Spine to become a world leader in AR-enabled spine solutions. The transaction is subject to approval and customary closing conditions and is expected to close in the coming weeks.
Related: Alkem MedTech announces majority acquisition of Occlutech in €99.4M deal
The xvision Spine System is designed to combine the benefits of navigation with the ease and utility of open surgery: visualization while looking directly at the patient, accuracy and precision, workflow efficiency, and radiation reduction. With nearly 13,000 patients treated with xvision, the transaction brings together two complementary portfolios focused on redefining spine care.
This transaction marks a foundational element in a broader enhanced visualization technology strategy for the company, building on the recent acquisition of the SpineHawk™ intraoperative spinal visualization platform from Robotron Surgical Technologies.
“We have long admired the xvision technology and potential of the platform,” said Marc Viscogliosi, co-CEO of VB Spine. “We believe with our implant integration and scale, we have the ability to harness the true potential of AR navigation. Combined with the SpineHawk platform, this will expand our existing spine solutions and supports our long-term roadmap to redefine spine care with differentiated technologies.”
“We are proud of the clinical impact xvision has made in spine surgery and VB Spine’s commitment to our world-class portfolio,” said Paul Ziegler, President and CEO of Augmedics. “This agreement will strengthen our competitive advantage as an augmented reality innovation engine as we turn our focus to expanding our reach into adjacent surgical indications.”
Subject to approval and closing, VB Spine and Augmedics intend to work together to support an orderly transition for customers.
